Efficacy and Safety of Melatonin and Clonazepam for IRBD

• Status: Completed
• Trial end date: 2020-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study aimed to evaluate influence of melatonin or clonazepam treatment on symptom and polysomnographic parameters in patients with idiopathic REM sleep behavior disorder.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kyung Hee University Hospital at Gangdong
• Treatments: Clonazepam; Melatonin

Criteria

Inclusion Criteria:

• REM sleep behavior disorder (ICSD-3 criteria)

Exclusion Criteria:

• Neurological disorder including epilepsy or stroke

• History of psychiatric illness

• Neurodegenerative disease including dementia or parkinsonism.

• Medication affecting sleep within 1 month

• Intake of melatonin or clonazepam within 1 week.

• Unable to complete questionnaires